Tag Archive for: Merkel cell carcinoma

Non-Melanoma Skin Cancers and Clinical Trials | Advancing Science for Everyone

Bookmark (0)

No account yet? Register

Non-Melanoma Skin Cancers and Clinical Trials: Advancing Science for Everyone from Patient Empowerment Network on Vimeo.

What is the value of non-melanoma skin cancer clinical trials? Expert Dr. Silvina Pugliese from explains why clinical trial participation is important and shares advice for patients.

Silvina Pugliese, M.D., is a Clinical Assistant Professor of Dermatology and Attending Physician at the Stanford Medicine Outpatient Center and Stanford Cancer Institute. Learn more about Dr. Pugliese.

[ACT]IVATION TIP

“…if you are interested in participating in a clinical trial, in advancing medical knowledge, and you feel comfortable doing so, please ask your dermatologist or your oncologist, whether they’re aware of any clinical trials that are available for your particular type of skin cancer.”

Download Guide  |  Download Guide en español

See More from [ACT]IVATED Non-Melanoma Skin Cancer

Related Resources:

Emerging Squamous Cell and Basal Cell Cancer Treatments | Challenges and Promises

Emerging Squamous Cell and Basal Cell Cancer Treatments: Challenges and Promises

What Should Non-Melanoma Skin Cancer Patients Consider About Treatment?

What Should Non-Melanoma Skin Cancer Patients Consider About Treatment?

Hopeful Outcomes In Immunotherapy for Non-Melanoma Skin Cancers

Hopeful Outcomes In Immunotherapy for Non-Melanoma Skin Cancers


Transcript:

Mary Leer:

Why is clinical trial participation so important in non-melanoma skin cancers, and what advice do you have for patients considering a clinical trial?

Dr. Silvina Pugliese:

This is a great question. So it is much more common to have early stage localized disease for basal cell cancer and squamous cell cancer. So the overall case number that we see for advanced or unresectable or metastatic disease for squamous cell cancer and especially for basal cell cancer is much lower than the usual numbers we hear of 4 million cases annually of basal cell cancer in the U.S., and 2 million of squamous cell cancer. And the reason this is important is because when we have a lower pool to evaluate or study, when we think about these more advanced skin cancers, we have less patients to recruit for some of these studies. This is especially important when we think about advanced or metastatic basal cell cancer, which is very rare.

Also very important we think about less common skin cancers like Merkel cell carcinoma or DFSP. And when we think about how uncommon these skin cancers can be in skin of color, we realize we’re really drawing from a very small pool of patients. So my point here is that you can make a true impact by enrolling in a clinical trial, especially as we’re looking at what are some of the best treatment options for these more advanced skin cancers or metastatic skin cancers? Because we do need the right patients to be enrolled in order to study these research questions.

So my activation tip is, if you are interested in participating in a clinical trial, in advancing medical knowledge, and you feel comfortable doing so, please ask your dermatologist or your oncologist, whether they’re aware of any clinical trials that are available for your particular type of skin cancer. Of course, never feel any pressure to do this, it’s completely optional, but often it can provide more, a novel treatment option for your cancer or allow you to have certain treatment that’s not available through insurance, for example, at the moment. And also in doing so, advance the knowledge that we have in our field and help patients in the future who have your same skin cancer and are in your same position. 


Share Your Feedback:

Create your own user feedback survey

Non-Melanoma Skin Cancer Subtypes | Are Some Populations More At-Risk?

Bookmark (0)

No account yet? Register

Non-Melanoma Skin Cancer Subtypes: Are Some Populations More At-Risk? from Patient Empowerment Network on Vimeo

Are some populations more at-risk for non-melanoma skin cancer subtypes? Expert Dr. Silvina Pugliese explains common subtypes, incidence rates, and risk factors linked with the subtypes.

Silvina Pugliese, M.D., is a Clinical Assistant Professor of Dermatology and Attending Physician at the Stanford Medicine Outpatient Center and Stanford Cancer Institute. Learn more about Dr. Pugliese.

[ACT]IVATION TIP

Patients who have any of the risk factors discussed, so, for example, lighter-skinned, chronic sun exposure, and immunosuppressed for any reason, whether due to an underlying medical condition or a medication, or who have genetic mutations or history of radiation or any environmental factors that put them at risk, should be aware that looking at their skin for skin cancers is very important, and that they should see a doctor, a dermatologist, if they notice anything that looks suspicious on their skin, that warrants for their evaluation.”

Download Guide  |  Download Guide en español

See More from [ACT]IVATED Non-Melanoma Skin Cancer

Related Resources:

Do Non-Melanoma Skin Cancers Differ in Diverse Patient Populations?

Do Non-Melanoma Skin Cancers Differ in Diverse Patient Populations?

Melanoma vs. Non-Melanoma Skin Cancer | What’s the Difference?

Melanoma vs. Non-Melanoma Skin Cancer | What’s the Difference?

Explaining Skin Cancer to Newly Diagnosed Patients | An Oncodermatologist Weighs In

Explaining Skin Cancer to Newly Diagnosed Patients | An Oncodermatologist Weighs In


Transcript:

Mary Leer:

All right. Dr. Pugliese, what are the various subtypes of non-melanoma skin cancers, and are certain populations more susceptible to getting non-melanoma skin cancers than others?

Dr. Silvina Pugliese:

So there are a number of subtypes of non-melanoma skin cancers. The most common one is called a basal cell cancer, that occurs in about 4 million, there are about 4 million cases of basal cell cancer in the United States every year, and it’s considered a skin cancer related to keratinocytes, the most common type of skin cell. The second most common type of non-melanoma skin cancer, is called a squamous cell cancer, also arising from keratinocytes with about 2 million cases diagnosed each year in the United States. There are also less common types of non-melanoma skin cancers, including Merkel cell carcinoma, which arises from Merkel cells and sebaceous carcinoma. 

When we think about risk factors, there are a number of risk factors that put certain populations at a higher risk of developing non-melanoma skin cancers. So, for example, one thing that we think about often is lighter skin. So patients who have blonde hair, red hair, freckles, who are more likely to sunburn, who have lighter skin, are going to be more prone to the UV damage that can cause some of these skin cancers to develop. Chronic sun exposure is closely interplayed with that concept, so patients that live in a warm climate, are closer to the equator, live at higher altitude, have outdoor hobbies or outdoor jobs. There are certain medications that can also confer a greater risk of developing non-melanoma skin cancers.

So medications that suppress your immune system or that making more sensitive to light or getting sunburns from UV. And any condition that suppresses the immune system. So, for example, patients that have undergone a solid organ transplant, like a heart transplant or a lung transplant, or patients that have a diagnosis such as chronic lymphocytic leukemia. We know that those patient populations are at much higher risk of developing non-melanoma cancers.

There are other factors that are environmental. So, for example, if there is arsenic in well water that is being bathed in, then that could also lead to development of squamous cell cancer, smoking, chronic wounds or scars can put certain patients at increased risk of squamous cell cancer, certain genetic mutations, and then a history of any radiation, for example, for the treatment of other types of cancer.

So my activation tip for this question is, there are a number of non-melanoma skin cancers that can present, the most common ones being basal cell cancer and squamous cell cancer. Patients who have any of the risk factors discussed, so, for example, lighter-skinned, chronic sun exposure, and immunosuppressed for any reason, whether due to an underlying medical condition or a medication, or who have genetic mutations or history of radiation or any environmental factors that put them at risk, should be aware that looking at their skin for skin cancers is very important, and that they should see a doctor, a dermatologist, if they notice anything that looks suspicious on their skin, that warrants for their evaluation.


Share Your Feedback:

Create your own user feedback survey